USANA (USNA) Director John Turman Converts 1,632 RSUs

What Happened John Turman, a director of USANA Health Sciences (USNA), had 1,632 restricted stock units (RSUs) convert to common shares on July 23, 2026 (reported as transaction code M — exercise/conversion of a derivative). The filing also reports an immediate disposition of those 1,632 shares at $0.00. Footnotes state each RSU represents a contingent right to one share and that RSUs vest 25% on July 23, 2026 (with remaining vesting on Oct 22, 2026; Jan 21, 2027; Apr 22, 2027).

Key Details

• Transaction date: July 23, 2026; Filing date: July 27, 2026 (filed within the SEC’s required window).
• Acquired via conversion (code M): 1,632 shares (acquisition price reported as N/A).
• Disposed: 1,632 shares reported at $0.00 (no sale proceeds shown in this Form 4).
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes: F1 = each RSU converts to one share; F2 = RSUs vest 25% on July 23, 2026 and on three subsequent dates.
• No 10b5-1 plan or tax-withholding specifics are listed in the supplied footnotes (disposition at $0.00 may reflect company settlement/withholding but the filing does not specify).

Context This appears to be a standard RSU vesting/conversion event for a director rather than an open-market buy or sale. The immediate disposition reported at $0.00 means the shares were not sold in the open market with proceeds shown on this Form 4; the filing itself does not state the reason for the disposition (e.g., tax withholding or net settlement). For retail investors, conversions/vestings are routine compensation events and do not, by themselves, indicate the director’s market view.